CRLBF
Price
$0.89
Change
+$0.01 (+1.14%)
Updated
Jan 17 closing price
Capitalization
501.04M
53 days until earnings call
MRMD
Price
$0.12
Change
+$0.01 (+9.09%)
Updated
Jan 17 closing price
Capitalization
137.81M
73 days until earnings call
Ad is loading...

CRLBF vs MRMD

Header iconCRLBF vs MRMD Comparison
Open Charts CRLBF vs MRMDBanner chart's image
Cresco Labs
Price$0.89
Change+$0.01 (+1.14%)
Volume$615.53K
Capitalization501.04M
MariMed
Price$0.12
Change+$0.01 (+9.09%)
Volume$311.71K
Capitalization137.81M
CRLBF vs MRMD Comparison Chart
Loading...
CRLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRLBF vs. MRMD commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRLBF is a Hold and MRMD is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (CRLBF: $0.89 vs. MRMD: $0.12)
Brand notoriety: CRLBF and MRMD are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CRLBF: 77% vs. MRMD: 61%
Market capitalization -- CRLBF: $501.04M vs. MRMD: $137.81M
CRLBF [@Pharmaceuticals: Other] is valued at $501.04M. MRMD’s [@Pharmaceuticals: Other] market capitalization is $137.81M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRLBF’s FA Score shows that 0 FA rating(s) are green whileMRMD’s FA Score has 0 green FA rating(s).

  • CRLBF’s FA Score: 0 green, 5 red.
  • MRMD’s FA Score: 0 green, 5 red.
According to our system of comparison, both CRLBF and MRMD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRLBF’s TA Score shows that 4 TA indicator(s) are bullish while MRMD’s TA Score has 3 bullish TA indicator(s).

  • CRLBF’s TA Score: 4 bullish, 3 bearish.
  • MRMD’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, CRLBF is a better buy in the short-term than MRMD.

Price Growth

CRLBF (@Pharmaceuticals: Other) experienced а -5.32% price change this week, while MRMD (@Pharmaceuticals: Other) price change was +3.42% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.30%. For the same industry, the average monthly price growth was +2.86%, and the average quarterly price growth was -9.85%.

Reported Earning Dates

CRLBF is expected to report earnings on May 14, 2025.

MRMD is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.30% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRLBF($501M) has a higher market cap than MRMD($138M). MRMD YTD gains are higher at: -0.691 vs. CRLBF (-2.597). MRMD has higher annual earnings (EBITDA): 22.7M vs. CRLBF (-16.73M). CRLBF has more cash in the bank: 88.8M vs. MRMD (21.7M). MRMD has less debt than CRLBF: MRMD (65M) vs CRLBF (678M). CRLBF has higher revenues than MRMD: CRLBF (822M) vs MRMD (137M).
CRLBFMRMDCRLBF / MRMD
Capitalization501M138M363%
EBITDA-16.73M22.7M-74%
Gain YTD-2.597-0.691376%
P/E RatioN/A13.33-
Revenue822M137M600%
Total Cash88.8M21.7M409%
Total Debt678M65M1,043%
FUNDAMENTALS RATINGS
CRLBF vs MRMD: Fundamental Ratings
CRLBF
MRMD
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
64
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9495
PRICE GROWTH RATING
1..100
9191
P/E GROWTH RATING
1..100
10097
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRLBF's Valuation (62) in the null industry is in the same range as MRMD (64). This means that CRLBF’s stock grew similarly to MRMD’s over the last 12 months.

CRLBF's Profit vs Risk Rating (100) in the null industry is in the same range as MRMD (100). This means that CRLBF’s stock grew similarly to MRMD’s over the last 12 months.

CRLBF's SMR Rating (94) in the null industry is in the same range as MRMD (95). This means that CRLBF’s stock grew similarly to MRMD’s over the last 12 months.

CRLBF's Price Growth Rating (91) in the null industry is in the same range as MRMD (91). This means that CRLBF’s stock grew similarly to MRMD’s over the last 12 months.

MRMD's P/E Growth Rating (97) in the null industry is in the same range as CRLBF (100). This means that MRMD’s stock grew similarly to CRLBF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRLBFMRMD
RSI
ODDS (%)
Bullish Trend 12 days ago
84%
N/A
Stochastic
ODDS (%)
Bearish Trend 12 days ago
89%
Bullish Trend 12 days ago
83%
Momentum
ODDS (%)
Bullish Trend 12 days ago
80%
Bearish Trend 12 days ago
90%
MACD
ODDS (%)
Bullish Trend 12 days ago
82%
Bullish Trend 12 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
82%
Bullish Trend 12 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
88%
Bearish Trend 12 days ago
90%
Advances
ODDS (%)
Bullish Trend 13 days ago
83%
Bullish Trend 17 days ago
81%
Declines
ODDS (%)
Bearish Trend 25 days ago
87%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 12 days ago
87%
Bearish Trend 12 days ago
90%
View a ticker or compare two or three
Ad is loading...
CRLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WFC77.081.13
+1.49%
Wells Fargo & Co
DAN12.920.06
+0.47%
Dana
GGR0.47N/A
+0.13%
Gogoro
WIX240.89-0.83
-0.34%
Wix.com Ltd
TLSA0.74-0.02
-2.64%
Tiziana Life Sciences Ltd

CRLBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRLBF has been closely correlated with TSNDF. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRLBF jumps, then TSNDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRLBF
1D Price
Change %
CRLBF100%
+0.63%
TSNDF - CRLBF
76%
Closely correlated
+8.08%
CURLF - CRLBF
76%
Closely correlated
+10.22%
TCNNF - CRLBF
75%
Closely correlated
+1.43%
JUSHF - CRLBF
74%
Closely correlated
+4.33%
VRNOF - CRLBF
73%
Closely correlated
+8.27%
More

MRMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRMD has been loosely correlated with TSNDF. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MRMD jumps, then TSNDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRMD
1D Price
Change %
MRMD100%
+1.77%
TSNDF - MRMD
45%
Loosely correlated
+8.08%
JUSHF - MRMD
43%
Loosely correlated
+4.33%
TCNNF - MRMD
41%
Loosely correlated
+1.43%
CRLBF - MRMD
40%
Loosely correlated
+0.63%
ACB - MRMD
39%
Loosely correlated
-2.78%
More